Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14

S. A. Kingsberg, S. Althof, J. A. Simon, A. Bradford, J. Bitzer, J. Carvalho, K. E. Flynn, R. E. Nappi, J. B. Reese, R. L. Rezaee, L. Schover, J. L. Shifrin

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Since the millennium we have witnessed significant strides in the science and treatment of female sexual dysfunction (FSD). This forward progress has included (i) the development of new theoretical models to describe healthy and dysfunctional sexual responses in women; (ii) alternative classification strategies of female sexual disorders; (iii) major advances in brain, hormonal, psychological, and interpersonal research focusing on etiologic factors and treatment approaches; (iv) strong and effective public advocacy for FSD; and (v) greater educational awareness of the impact of FSD on the woman and her partner. AIMS: To review the literature and describe the best practices for assessing and treating women with hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. METHODS: The committee undertook a comprehensive review of the literature and discussion among themselves to determine the best assessment and treatment methods. RESULTS: Using a biopsychosocial lens, the committee presents recommendations (with levels of evidence) for assessment and treatment of hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. CONCLUSION: The numerous significant strides in FSD that have occurred since the previous International Consultation of Sexual Medicine publications are reviewed in this article. Although evidence supports an integrated biopsychosocial approach to assessment and treatment of these disorders, the biological and psychological factors are artificially separated for review purposes. We recognize that best outcomes are achieved when all relevant factors are identified and addressed by the clinician and patient working together in concert (the sum is greater than the whole of its parts). Kingsberg SA, Althof S, Simon JA, et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. J Sex Med 2017;14:1463-1491.
Original languageEnglish
Pages (from-to)1463-1491
Number of pages29
JournalJournal of Sexual Medicine
Volume14
Issue number12
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Psychological Sexual Dysfunctions
Therapeutics
Consumer Advocacy
Psychology
Biological Factors
Practice Guidelines
Lenses
Publications
Theoretical Models
Referral and Consultation

Keywords

  • Advisory Committees/standards
  • Female
  • Humans
  • Male
  • Orgasm
  • Psychotherapy/organization & administration/standards
  • Sexual Behavior/psychology
  • Sexual Dysfunctions, Psychological/psychology/therapy
  • Female Orgasmic Dysfunction
  • Female Sexual Arousal Disorder
  • Female Sexual Dysfunction
  • Hypoactive Sexual Desire Disorder
  • Persistent Genital Arousal Disorder

Cite this

Kingsberg, S. A., Althof, S., Simon, J. A., Bradford, A., Bitzer, J., Carvalho, J., ... Shifrin, J. L. (2017). Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. Journal of Sexual Medicine, 14(12), 1463-1491. https://doi.org/S1743-6095(17)31532-1 [pii]

Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. / Kingsberg, S. A.; Althof, S.; Simon, J. A.; Bradford, A.; Bitzer, J.; Carvalho, J.; Flynn, K. E.; Nappi, R. E.; Reese, J. B.; Rezaee, R. L.; Schover, L.; Shifrin, J. L.

In: Journal of Sexual Medicine, Vol. 14, No. 12, 01.12.2017, p. 1463-1491.

Research output: Contribution to journalArticle

Kingsberg, SA, Althof, S, Simon, JA, Bradford, A, Bitzer, J, Carvalho, J, Flynn, KE, Nappi, RE, Reese, JB, Rezaee, RL, Schover, L & Shifrin, JL 2017, 'Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14', Journal of Sexual Medicine, vol. 14, no. 12, pp. 1463-1491. https://doi.org/S1743-6095(17)31532-1 [pii]
Kingsberg SA, Althof S, Simon JA, Bradford A, Bitzer J, Carvalho J et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. Journal of Sexual Medicine. 2017 Dec 1;14(12):1463-1491. https://doi.org/S1743-6095(17)31532-1 [pii]
Kingsberg, S. A. ; Althof, S. ; Simon, J. A. ; Bradford, A. ; Bitzer, J. ; Carvalho, J. ; Flynn, K. E. ; Nappi, R. E. ; Reese, J. B. ; Rezaee, R. L. ; Schover, L. ; Shifrin, J. L. / Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. In: Journal of Sexual Medicine. 2017 ; Vol. 14, No. 12. pp. 1463-1491.
@article{326e575c5ec042c3b7cf6d54dea18772,
title = "Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14",
abstract = "INTRODUCTION: Since the millennium we have witnessed significant strides in the science and treatment of female sexual dysfunction (FSD). This forward progress has included (i) the development of new theoretical models to describe healthy and dysfunctional sexual responses in women; (ii) alternative classification strategies of female sexual disorders; (iii) major advances in brain, hormonal, psychological, and interpersonal research focusing on etiologic factors and treatment approaches; (iv) strong and effective public advocacy for FSD; and (v) greater educational awareness of the impact of FSD on the woman and her partner. AIMS: To review the literature and describe the best practices for assessing and treating women with hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. METHODS: The committee undertook a comprehensive review of the literature and discussion among themselves to determine the best assessment and treatment methods. RESULTS: Using a biopsychosocial lens, the committee presents recommendations (with levels of evidence) for assessment and treatment of hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. CONCLUSION: The numerous significant strides in FSD that have occurred since the previous International Consultation of Sexual Medicine publications are reviewed in this article. Although evidence supports an integrated biopsychosocial approach to assessment and treatment of these disorders, the biological and psychological factors are artificially separated for review purposes. We recognize that best outcomes are achieved when all relevant factors are identified and addressed by the clinician and patient working together in concert (the sum is greater than the whole of its parts). Kingsberg SA, Althof S, Simon JA, et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. J Sex Med 2017;14:1463-1491.",
keywords = "Advisory Committees/standards, Female, Humans, Male, Orgasm, Psychotherapy/organization & administration/standards, Sexual Behavior/psychology, Sexual Dysfunctions, Psychological/psychology/therapy, Female Orgasmic Dysfunction, Female Sexual Arousal Disorder, Female Sexual Dysfunction, Hypoactive Sexual Desire Disorder, Persistent Genital Arousal Disorder",
author = "Kingsberg, {S. A.} and S. Althof and Simon, {J. A.} and A. Bradford and J. Bitzer and J. Carvalho and Flynn, {K. E.} and Nappi, {R. E.} and Reese, {J. B.} and Rezaee, {R. L.} and L. Schover and Shifrin, {J. L.}",
note = "LR: 20180209; CI: Copyright (c) 2017; JID: 101230693; EIN: J Sex Med. 2018 Feb;15(2):270. PMID: 29425667; OTO: NOTNLM; 2016/12/23 00:00 [received]; 2017/05/15 00:00 [revised]; 2017/05/17 00:00 [accepted]; 2017/12/05 06:00 [entrez]; 2017/12/05 06:00 [pubmed]; 2018/01/26 06:00 [medline]; ppublish",
year = "2017",
month = "12",
day = "1",
doi = "S1743-6095(17)31532-1 [pii]",
language = "English",
volume = "14",
pages = "1463--1491",
journal = "Journal of Sexual Medicine",
issn = "1743-6095",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14

AU - Kingsberg, S. A.

AU - Althof, S.

AU - Simon, J. A.

AU - Bradford, A.

AU - Bitzer, J.

AU - Carvalho, J.

AU - Flynn, K. E.

AU - Nappi, R. E.

AU - Reese, J. B.

AU - Rezaee, R. L.

AU - Schover, L.

AU - Shifrin, J. L.

N1 - LR: 20180209; CI: Copyright (c) 2017; JID: 101230693; EIN: J Sex Med. 2018 Feb;15(2):270. PMID: 29425667; OTO: NOTNLM; 2016/12/23 00:00 [received]; 2017/05/15 00:00 [revised]; 2017/05/17 00:00 [accepted]; 2017/12/05 06:00 [entrez]; 2017/12/05 06:00 [pubmed]; 2018/01/26 06:00 [medline]; ppublish

PY - 2017/12/1

Y1 - 2017/12/1

N2 - INTRODUCTION: Since the millennium we have witnessed significant strides in the science and treatment of female sexual dysfunction (FSD). This forward progress has included (i) the development of new theoretical models to describe healthy and dysfunctional sexual responses in women; (ii) alternative classification strategies of female sexual disorders; (iii) major advances in brain, hormonal, psychological, and interpersonal research focusing on etiologic factors and treatment approaches; (iv) strong and effective public advocacy for FSD; and (v) greater educational awareness of the impact of FSD on the woman and her partner. AIMS: To review the literature and describe the best practices for assessing and treating women with hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. METHODS: The committee undertook a comprehensive review of the literature and discussion among themselves to determine the best assessment and treatment methods. RESULTS: Using a biopsychosocial lens, the committee presents recommendations (with levels of evidence) for assessment and treatment of hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. CONCLUSION: The numerous significant strides in FSD that have occurred since the previous International Consultation of Sexual Medicine publications are reviewed in this article. Although evidence supports an integrated biopsychosocial approach to assessment and treatment of these disorders, the biological and psychological factors are artificially separated for review purposes. We recognize that best outcomes are achieved when all relevant factors are identified and addressed by the clinician and patient working together in concert (the sum is greater than the whole of its parts). Kingsberg SA, Althof S, Simon JA, et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. J Sex Med 2017;14:1463-1491.

AB - INTRODUCTION: Since the millennium we have witnessed significant strides in the science and treatment of female sexual dysfunction (FSD). This forward progress has included (i) the development of new theoretical models to describe healthy and dysfunctional sexual responses in women; (ii) alternative classification strategies of female sexual disorders; (iii) major advances in brain, hormonal, psychological, and interpersonal research focusing on etiologic factors and treatment approaches; (iv) strong and effective public advocacy for FSD; and (v) greater educational awareness of the impact of FSD on the woman and her partner. AIMS: To review the literature and describe the best practices for assessing and treating women with hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. METHODS: The committee undertook a comprehensive review of the literature and discussion among themselves to determine the best assessment and treatment methods. RESULTS: Using a biopsychosocial lens, the committee presents recommendations (with levels of evidence) for assessment and treatment of hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. CONCLUSION: The numerous significant strides in FSD that have occurred since the previous International Consultation of Sexual Medicine publications are reviewed in this article. Although evidence supports an integrated biopsychosocial approach to assessment and treatment of these disorders, the biological and psychological factors are artificially separated for review purposes. We recognize that best outcomes are achieved when all relevant factors are identified and addressed by the clinician and patient working together in concert (the sum is greater than the whole of its parts). Kingsberg SA, Althof S, Simon JA, et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. J Sex Med 2017;14:1463-1491.

KW - Advisory Committees/standards

KW - Female

KW - Humans

KW - Male

KW - Orgasm

KW - Psychotherapy/organization & administration/standards

KW - Sexual Behavior/psychology

KW - Sexual Dysfunctions, Psychological/psychology/therapy

KW - Female Orgasmic Dysfunction

KW - Female Sexual Arousal Disorder

KW - Female Sexual Dysfunction

KW - Hypoactive Sexual Desire Disorder

KW - Persistent Genital Arousal Disorder

U2 - S1743-6095(17)31532-1 [pii]

DO - S1743-6095(17)31532-1 [pii]

M3 - Article

VL - 14

SP - 1463

EP - 1491

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 12

ER -